Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Shufeng Xingbi Therapy Restores Immune and Microbiota Balanc
2026-07-29
The referenced study demonstrates that Shufeng Xingbi Therapy (SFXBT) effectively rebalances Th1/Th2 immune responses and remodels intestinal flora in a rat model of allergic rhinitis. These findings highlight the mechanistic interplay between immune regulation and gut microbiota, informing future translational research on allergic inflammation.
-
Smoothened Agonist (SAG): Precision Tools for Hedgehog Pathw
2026-07-29
Explore the advanced use of Smoothened Agonist (SAG) as a potent Smoothened receptor agonist for Hedgehog pathway research. This article unpacks new mechanistic insights and protocol guidance, with a special focus on developmental biology and teratogenicity models.
-
AG-120 (Ivosidenib): Metabolic Reversal and Resistance in ID
2026-07-28
Explore how AG-120 (Ivosidenib) achieves precise 2-hydroxyglutarate reduction in IDH1 mutant AML and why understanding CD44-mediated metabolic rewiring is essential for overcoming resistance. This in-depth analysis offers unique, evidence-backed insights on assay design and therapeutic strategy.
-
Distinct Aggregation Patterns of TDP-43: Mechanistic Insight
2026-07-28
This study uncovers how loss of TDP-43 oligomerization or RNA binding leads to distinct aggregation patterns relevant to ALS and FTLD. The work delineates mechanistic pathways underlying pathological TDP-43 inclusions and highlights implications for neurodegenerative disease models.
-
Dexamethasone (DHAP): Glucocorticoid Anti-Inflammatory Insig
2026-07-27
Dexamethasone (DHAP) is a synthetic glucocorticoid anti-inflammatory widely used to inhibit NF-κB signaling and modulate immune responses in bench research. Its robust effects on dendritic cell differentiation, stem cell fate, and neuroinflammatory pathways are supported by peer-reviewed and product-validated evidence. This article provides a structured overview of DHAP's mechanisms, evidence benchmarks, and best practices for laboratory integration.
-
Superoxide Dismutase (SOD) Activity Assay Kit: Protocol & QC
2026-07-27
The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) enables sensitive, quantitative measurement of SOD enzyme activity in biological samples, supporting oxidative stress and antioxidative enzyme research workflows. It is designed for research use only and is not recommended for diagnostic or clinical applications.
-
Foretinib (GSK1363089): Optimizing Cancer Cell Assays In Vit
2026-07-26
Discover how Foretinib (GSK1363089) empowers advanced in vitro cancer research with robust multikinase inhibition. This guide details experimental workflows, troubleshooting insights, and protocol refinements to maximize reproducibility and mechanistic clarity in tumor cell growth and motility assays.
-
Decoupling Tumor Growth Inhibition and Cell Death in Drug Re
2026-07-25
The dissertation by Hannah R. Schwartz introduces a nuanced approach to evaluating anticancer drug responses in vitro, distinguishing between cell proliferation arrest and actual cell death. This work highlights the need for refined assay strategies to accurately capture the multifaceted effects of agents like Foretinib (GSK1363089), informing more precise experimental readouts and translational relevance.
-
Jasplakinolide: Precision Actin Polymerization Inducer Workf
2026-07-24
Jasplakinolide, a potent actin polymerization inducer, is revolutionizing cytoskeletal research with its high-affinity F-actin stabilization and membrane permeability. Explore advanced experimental workflows, optimization strategies, and troubleshooting tips that set this tool apart from traditional actin modulators.
-
RG108 in Epigenetic Gene Regulation: Reliable Workflows & Da
2026-07-24
This article guides life science researchers through practical assay challenges in epigenetic gene modulation, using RG108 (SKU A1913) as a benchmark DNA methyltransferase inhibitor. Drawing on evidence and real-world workflow scenarios, it demonstrates how RG108 supports reproducible, quantitative, and safe experimental design.
-
Chlorpromazine HCl: Unveiling Dopamine Antagonist Roles in E
2026-07-23
Explore the advanced neuropharmacological and cell biology applications of Chlorpromazine HCl, a leading dopamine receptor antagonist. This article uniquely bridges mechanistic insights with practical assay choices, revealing novel uses in endocytic pathway research.
-
DNase I (RNase-free): Precision DNA Removal for RNA Extracti
2026-07-23
DNase I (RNase-free) from APExBIO delivers highly efficient, ribonuclease-free DNA removal for critical workflows, including RNA extraction and in vitro transcription. Its flexibility and robust activity bridge the gap between routine sample prep and advanced vaccine research, empowering researchers to achieve uncompromised RNA purity and reproducible results.
-
Angiotensin III (human, mouse): Mechanistic Insights & Trans
2026-07-22
Explore the unique role of Angiotensin III in cardiovascular and neuroendocrine research. This in-depth analysis reveals mechanistic distinctions, practical assay guidance, and how new evidence informs experimental models using this pivotal peptide.
-
Parthenolide-Induced ROS Apoptosis in Lymphoid Malignancies
2026-07-22
This study demonstrates that parthenolide, a natural NF-κB inhibitor, induces apoptosis in diverse lymphoid malignancy cell lines via ROS-mediated mechanisms. Using a resazurin-based cell viability assay, the research highlights cell line–specific responses, supporting further exploration of parthenolide as a targeted therapeutic approach.
-
Br-DAPI: High-Sensitivity DAPI Fluorescent Dye for DNA Stain
2026-07-21
Br-DAPI advances DNA quantification and visualization in both live and fixed cell workflows, offering superior fluorescence sensitivity and selectivity. This next-generation DAPI fluorescent dye from APExBIO streamlines experimental reproducibility and troubleshooting, empowering researchers to achieve higher signal-to-noise in demanding applications.